中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:( Keiichiro Hirose)

1.8-week Safety Profile of Tapentadol Extended Release Tablets Switched from Other Opioids for Well-controlled, Moderate to Severe, Chronic Malignant Tumor-related Pain: Constipation, Nausea, Vomiting and Somnolence

Keiichiro Imanaka ; Takashi Yoshimura ; Yushin Tominaga ; Hiromi Koga ; Keiichiro Hirose

Palliative Care Research 2016;11(1):116-122

2.A Multicenter, Open-label Study of Tapentadol Extended-release Tablets in Opioid-naïve and Opioid-switching Subjects with Moderate to Severe Cancer Pain

Keiichiro Imanaka ; Takashi Yoshimura ; Yushin Tominaga ; Hiromi Koga ; Keiichiro Hirose

Palliative Care Research 2016;11(2):147-155

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO